Chun-Bing Chen

39PUBLICATIONS
51CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMajor global burdens of diseasePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Dec 31, 2024
Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade.

Chun-Bing Chen, Shuen-Iu Hung, John Wen-Cheng Chang

|Nov 06, 2024
CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity.

Tsu-Man Chiu, Chun-Bing Chen, Chun-Wei Lu

|Aug 14, 2024
Recent progress in Stevens-Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment.

Natsumi Hama, Shigeki Aoki, Chun-Bing Chen

|Aug 12, 2023
Axitinib Rechallenge Restores the Anticancer Effect after Nivolumab: A Case Report.

Yueh-Shih Chang, Pei-Hung Chang, Deng-Huang Wang

|Apr 28, 2023
Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.

Ching-Ya Wang, Chuang-Wei Wang, Chun-Bing Chen

Pageof 7